Actively Recruiting

Age: 18Years +
All Genders
NCT07047495

Personalization of External Beam Radiation Therapy in Localised Tumours

Led by European Institute of Oncology · Updated on 2025-07-02

35

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study will include the prospective acquisition of optimized MR imaging data of prostate and breast patients treated with radiotherapy (RT). Within the prospective study, biological specimens from patients undergoing in-room biopsy before RT, will be collected. Histological evaluation and cell culture (and organoid preparation) will be conducted, and samples/organoids will be irradiated with RT for biological validation.

CONDITIONS

Official Title

Personalization of External Beam Radiation Therapy in Localised Tumours

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged over 18 years
  • Unifocal infiltrating ductal breast carcinoma, non-special histotype
  • Clinical stage T1-T2, N0
  • No contraindications to MRI or metal joint prostheses from knee to shoulder or femoral stent
  • Good general condition (ECOG 0-2)
  • Expected active treatment such as crioablation, surgery, or radiotherapy
Not Eligible

You will not qualify if you...

  • Nodule involvement and metastasis (cN1 and/or cM1) for prostate patients
  • Concomitant inflammation of the intestine
  • Significant systemic diseases or ongoing oral anticoagulant therapy
  • Non-compliance with dose constraints in the treatment plan
  • Previous invasive cancer unless disease-free for at least 3 years
  • Mental disorders preventing valid informed consent
  • Histology other than non-special histotype and non-epithelial tumors for breast patients
  • Male sex for breast patients
  • High-risk mutation carrier patients
  • Bilateral breast cancer
  • Synchronous distant metastases
  • Neoadjuvant therapy
  • Autoimmune connective tissue diseases
  • Previous radiotherapy to the chest

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

European Institute of Oncology

Milan, Italy, Italy, 20141

Actively Recruiting

Loading map...

Research Team

G

Giulia Marvaso, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here